Are you Dr. Tsoukas?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Connect with colleagues in the same hospital or clinic
You already have 5 invites waiting! - Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
41 Mall Rd
Burlington, MA 01803Phone+1 781-744-5100- Is this information wrong?
Summary
- Dr. Michael Tsoukas, MD is an internist in Burlington, Massachusetts. He is currently licensed to practice medicine in Massachusetts.
Certifications & Licensure
- MA State Medical License 2013 - 2015
Clinical Trials
- Insulin-plus-pramlintide Closed-loop Strategy to Regulate Glucose Levels Without Carbohydrate Counting Start of enrollment: 2019 Feb 08
- Low Dose Empagliflozin in Adults With Type 1 Diabetes on Closed Loop Insulin System Start of enrollment: 2020 Nov 02
Publications & Presentations
PubMed
- 4 citationsStrategically Playing with Fire: SGLT Inhibitors as Possible Adjunct to Closed-Loop Insulin Therapy.Melissa-Rosina Pasqua, Michael A. Tsoukas, Ahmad Haidar> ;Journal of Diabetes Science and Technology. 2021 Sep 24
- 15 citationsA fully artificial pancreas versus a hybrid artificial pancreas for type 1 diabetes: a single-centre, open-label, randomised controlled, crossover, non-inferiority trial.Michael A. Tsoukas, Dorsa Majdpour, Jean-François Yale, Anas El Fathi, Natasha Garfield, Joanna Rutkowski, Jennifer Rene, Laurent Legault, Ahmad Haidar> ;The Lancet. Digital Health. 2021 Sep 24
- 9 citationsAlleviating carbohydrate counting with a FiASP-plus-pramlintide closed-loop delivery system (artificial pancreas): Feasibility and pilot studies.Michael A. Tsoukas, Elisa Cohen, Laurent Legault, Julia E. Von Oettingen, Jean-François Yale, Michael Vallis, Madison Odabassian, Anas El Fathi, Joanna Rutkowski, Adna...> ;Diabetes, Obesity & Metabolism. 2021 Sep 1
- Join now to see all